IDMoS aims for £2m in share placing:
This article was originally published in Clinica
IDMoS (Dundee, Scotland), a specialist in producing disease detection and monitoring technology, is expecting to raise £2m ($3.98m) before expenses through the conditional placing of around 5.25 million shares at 35p per share. The financing is conditional, on admission of the shares trading on the UK AIM stock exchange and the approval by shareholders of certain resolutions. The company intends to use the proceeds for the launch of its dental decay detection and monitoring products, the Caries Detection Device (CDD) and its Caries Management Support System (CMSS), which are expected to go on sale in the US and European markets later this year.
You may also be interested in...
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.